■持续使用阿片类药物是众所周知的手术后并发症。我们的目的是确定患者的种族或民族与术后一年持续使用阿片类药物之间是否存在关联。术后最初3、6和12个月的阿片类药物使用被归类为“持续早期”,持久性,慢性,分别。
■接受过开腹手术治疗的成人(≥18岁)的单机构回顾性研究。多变量逻辑回归用于评估种族/民族与阿片类药物使用之间的关联。
■在纳入研究的3523名患者中,2543(72.2%)是非西班牙裔(NH)白人,476(13.5%)是西班牙裔或拉丁裔,262(7.4%)为NH-Black,186人(5.3%)为亚洲人,56人(1.6%)属于其他种族或族裔。持续早期的总体比率,持久性,长期使用阿片类药物占15.9%,7.1%,和2.6%,分别。在多变量分析中,患者种族/民族与术后早期持续使用阿片类药物相关(p值=0.037),西班牙裔/拉丁裔的几率明显高于NH-白人(OR=1.382[95%CI:1.057-1.808];p=0.018)。然而,持续使用和长期使用阿片类药物均与种族/民族无关(分别为p=0.697和p=0.443).
■在这项对接受腹部开放手术的成年人的回顾性研究中,患者种族/民族与术后前12个月持续使用阿片类药物的发展并不一致.
UNASSIGNED: Sustained opioid use is a well-known complication after surgery. Our objective was to determine whether there is any association between a patient\'s race or ethnicity and the sustained use of opioids in the year following surgery. Opioid use over the initial 3, 6, and 12 postoperative months was categorized as \"sustained early\",
persistent, and chronic, respectively.
UNASSIGNED: Single-institution retrospective study of adults (≥18 years) who had undergone open abdominal surgery for cancer. Multivariable logistic regression was used to evaluate the association between race/ethnicity and opioid use.
UNASSIGNED: Of the 3523 patients included in the study, 2543 (72.2%) were non-Hispanic (NH) White, 476 (13.5%) were Hispanic or Latino, 262 (7.4%) were NH-Black, 186 (5.3%) were Asian, and 56 (1.6%) belonged to other racial or ethnic groups. The overall rates of sustained early,
persistent, and chronic opioid use were 15.9%, 7.1%, and 2.6%, respectively. In the multivariable analysis, patient race/ethnicity was associated with sustained early postoperative opioid use (p-value=0.037), with Hispanics/Latinos having significantly higher odds than NH-Whites (OR = 1.382 [95% CI: 1.057-1.808]; p = 0.018). However, neither
persistent nor chronic opioid use was associated with race/ethnicity (p = 0.697 and p = 0.443, respectively).
UNASSIGNED: In this retrospective study of adults who had undergone open abdominal surgery, patient race/ethnicity was not consistently associated with the development of sustained opioid use over the first 12 postoperative months.